| 产品描述: | FX-909 is a covalent peroxisome proliferator-activated receptor gamma (PPARG) inverse agonist. FX-909 can be used for the research of cancer[1]. |
| 靶点: |
PPARγ |
| 体外研究: |
FX-909 (0.03-1 mg/kg; BID for 21 days) 在 UMUC9 UC 异种移植小鼠模型中显示出抗癌作用[1]。 |
| 参考文献: |
1. Mertz J A, et al. Development of a surrogate tissue pharmacodynamic (PD) assay for clinical use with FX-909, a novel inhibitor of the urothelial luminal lineage transcription factor peroxisome proliferator-activated receptor gamma (PPARG). Cancer Research, 2023, 83(7_Supplement): 2802-2802. |
| 保存条件: |
-80°C 6个月;-20°C 1个月 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.775 ml |
13.876 ml |
27.752 ml |
| 5 mM |
0.555 ml |
2.775 ml |
5.55 ml |
| 10 mM |
0.278 ml |
1.388 ml |
2.775 ml |
| 50 mM |
0.056 ml |
0.278 ml |
0.555 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |